Term | Count | Pvalue | |||
Neuroactive ligand-receptor interaction | 22 | 9.07775E−22 | |||
AGE-RAGE signaling pathway in diabetic complications | 14 | 2.82127E−17 | |||
Fluid shear stress and atherosclerosis | 14 | 1.6426E−15 | |||
Non-alcoholic fatty liver disease | 14 | 1.90333E−14 | |||
cAMP signaling pathway | 15 | 5.65367E−14 | |||
cGMP-PKG signaling pathway | 13 | 2.78556E−13 | |||
Inflammatory bowel disease | 9 | 9.4159E−12 | |||
Adipocytokine signaling pathway | 9 | 1.64559E−11 | |||
Calcium signaling pathway | 12 | 2.26665E−11 | |||
IL-17 signaling pathway | 9 | 2.56325E−10 | |||
HIF-1 signaling pathway | 9 | 2.34888E−09 | |||
TNF signaling pathway | 8 | 2.21697E−08 | |||
AMPK signaling pathway | 8 | 5.07055E−08 | |||
inflammatory mediator regulation of trp channels | 7 | 3.35772E−07 | |||
Toll-like receptor signaling pathway | 7 | 3.35772E−07 | |||
NOD-like receptor signaling pathway | 7 | 8.99714E−06 | |||
Drug metabolism-cytochrome P450 | 5 | 1.28935E−05 | |||
Glycine, serine and threonine metabolism | 4 | 2.60439E−05 | |||
Adrenergic signaling in cardiomyocytes | 6 | 3.76567E−05 | |||
NF-kappa B signaling pathway | 5 | 5.66793E−05 | |||